文献速递区域麻醉与超声疼痛医学

2010至2018年乳房切除与肿块切除中周围神经阻滞使用趋势:国家数据库分析

Trends in Peripheral Nerve Block Usage in Mastectomy and Lumpectomy: Analysis of a National Database From 2010 to 2018.
PubMed 文献 · Anesth Analg · 2021-01-01

基于美国麻醉质量研究所国家麻醉临床结局注册库(AQI NACOR)2010至2018年189,854例乳房肿块切除与乳房切除手术病例,分析周围神经阻滞(PNB)使用趋势及相关因素。结果显示肿块切除PNB比例从2010年<0.1%升至2018年1.9%,乳房切除从0.5%升至13%,2014年后 odds 每年显著增加,但绝对使用率仍低。

要点

  • 2010至2018年乳房手术PNB使用率逐年上升,但总体绝对水平仍低。
  • 2014年后乳房切除PNB odds 每年增加2.24倍,肿块切除每年增加2.03倍。
  • 乳房切除中,2014年及以后年份、女性、设施区域和組織擴張器使用与更高PNB odds 相关。

核心结论

  • 2010至2018年乳房切除与肿块切除的PNB年使用率增加,但绝对流行率仍低。
  • 两种手术的PNB使用均与手术年份相关,尤其在2014年后更为明显。

研究设计与样本

  • 基于AQI NACOR数据库的回顾性分析,纳入2010至2018年189,854例符合标准的乳房肿块切除与乳房切除手术病例。
  • 采用分段混合效应logistic回归(以设施标识聚类)建模手术年份与PNB使用的非线性关联,并用混合效应logistic回归分析相关因素。

主要发现

  • 189,854例中86.2%为肿块切除,13.8%为乳房切除。
  • 肿块切除PNB比例从2010年<0.1%增至2018年1.9%(趋势P < .0001)。
  • 乳房切除PNB比例从2010年0.5%增至2018年13%(趋势P < .0001)。
  • 2014年后乳房切除PNB的odds每年增加2.24倍(95%CI 2.00-2.49;P < .001),2014年前后交互检验P < .001。
  • 2014年后肿块切除PNB的odds每年增加2.03倍(95%CI 1.81-2.27;P < .001),2014年前后交互检验P < .001。

关键数值与推荐

  • 乳房切除队列中,手术年份≥2014、女性、设施区域和組織擴張器使用与更高PNB odds 相关。
  • 肿块切除队列中,手术年份≥2014和设施区域与更高PNB使用odds 相关。

临床怎么用

  • 解读乳房手术PNB使用趋势时需注意2014年后增长加速但绝对使用率仍低。
  • 可关注乳房切除中女性、特定设施区域及組織擴張器使用等与PNB使用相关的因素。

局限性

  • 原文摘要未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Compared to general anesthesia, regional anesthesia confers several benefits including improved pain control and decreased postoperative opioid consumption. While the benefits of peripheral nerve blocks (PNB) have been well studied, there are little epidemiological data on PNB usage in mastectomy and lumpectomy procedures. The primary objective of our study was to assess national trends of the annual proportion of PNB use in breast surgery from 2010 to 2018. We also identified factors associated with PNB use for breast surgery. METHODS: We identified lumpectomy and mastectomy surgical cases with and without PNB between 2010 and 2018 using the Anesthesia Quality Institute National Anesthesia Clinical Outcomes Registry (AQI NACOR). We modeled the nonlinear association between year of procedure and PNB use with segmented mixed-effects logistic regression clustered on facility identifier. The association between PNB use and year of procedure, age, sex, American Society of Anesthesiologists physical status (ASA PS), facility type, facility region, weekday, and tissue expander use was also modeled using mixed-effects logistic regression. RESULTS: Of the 189,854 surgical cases from 2010 to 2018 that met criteria, 86.2% were lumpectomy cases and 13.8% were mastectomy cases. The proportion of lumpectomy cases with PNB was <0.1% in 2010 and increased each subsequent year to 1.9% in 2018 (trend P < .0001). The proportion of mastectomy cases with PNB was 0.5% in 2010 and 13% in 2018 (trend P < .0001). The year 2014 was the breakpoint selected for segmented regression. Before 2014, the odds of PNB among the mastectomy cases was not significantly different from year to year. After 2014, the odds of PNB increased by 2.24-fold each year (95% confidence interval [CI], 2.00-2.49; P < .001); interaction test for pre-2014 versus post-2014 was P < .001. Similar trends were seen in the lumpectomy cases, where after 2014, the odds of PNB increased by 2.03-fold (95% CI, 1.81-2.27; P < .001); interaction test for pre-2014 versus post-2014 was P < .001. In the mastectomy cohort, year of procedure ≥2014, female sex, facility region, and tissue expander use were associated with higher odds of PNB. For lumpectomy cases, year of procedure ≥2014 and facility region were associated with higher odds of PNB use. CONCLUSIONS: We found increased annual utilization of PNB for mastectomy and lumpectomy since 2010, although absolute prevalence is low. PNB use was associated with year of procedure for both lumpectomy and mastectomy, particularly post-2014.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Lam S, Qu H, Hannum M, et al. Trends in Peripheral Nerve Block Usage in Mastectomy and Lumpectomy: Analysis of a National Database From 2010 to 2018. Anesth Analg. 2021. PMID: 33481402. doi:10.1213/ANE.0000000000005368

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。